Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsant hypersensitivity syndrome

A R Morkunas1, M B Miller

  • 1Department of Medical Education, Good Samaritan Regional Medical Center, Phoenix, Arizona, USA.

Critical Care Clinics
|October 23, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies.

Placenta·2022
Same author

Diagnostic accuracy of the Xpert<sup>®</sup> MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Occurrence of methicillin-resistant Staphylococcus aureus in surface waters near industrial hog operation spray fields.

The Science of the total environment·2016
Same author

Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.

Translational psychiatry·2016
Same author

Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

The pharmacogenomics journal·2015
Same author

Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Anticonvulsant hypersensitivity syndrome (AHS) is a rare, severe reaction to certain anti-seizure drugs. Early recognition of fever, rash, and swollen lymph nodes is crucial for timely diagnosis and management.

Area of Science:

  • Pharmacology
  • Clinical Toxicology
  • Dermatology

Background:

  • Anticonvulsant hypersensitivity syndrome (AHS) is a severe adverse drug reaction.
  • It is associated with anticonvulsant medications like phenytoin, carbamazepine, and phenobarbital.
  • AHS presents with diverse clinical features, often delaying diagnosis.

Purpose of the Study:

  • To highlight the clinical features of Anticonvulsant hypersensitivity syndrome (AHS).
  • To emphasize the importance of early recognition and diagnosis of AHS.
  • To inform clinicians about a potentially fatal adverse drug reaction.

Main Methods:

  • Review of clinical presentations associated with Anticonvulsant hypersensitivity syndrome.
  • Analysis of common diagnostic delays and key clinical indicators.

Related Experiment Videos

  • Emphasis on the typical timeline of symptom onset after drug initiation.

    • Main Results:

    • AHS commonly manifests within 3 weeks of starting anticonvulsant therapy.
    • Key symptoms include fever, rash (variable type and severity), and lymphadenopathy.
    • The syndrome's varied presentation can lead to diagnostic challenges.

    Conclusions:

    • A high index of suspicion for AHS is warranted in patients presenting with fever, rash, and lymphadenopathy.
    • Prompt diagnosis and withdrawal of the offending anticonvulsant are critical.
    • Understanding AHS clinical patterns aids in preventing severe outcomes.